The University of Chicago Header Logo

Connection

Kathleen Mullane to Antifungal Agents

This is a "connection" page, showing publications Kathleen Mullane has written about Antifungal Agents.
Connection Strength

1.960
  1. Isavuconazole for treatment of rare invasive fungal diseases. Mycoses. 2018 Aug; 61(8):518-533.
    View in: PubMed
    Score: 0.593
  2. Posaconazole salvage therapy allows successful allogeneic hematopoietic stem cell transplantation in patients with refractory invasive mold infections. Transpl Infect Dis. 2007 Jun; 9(2):89-96.
    View in: PubMed
    Score: 0.273
  3. Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species. Mycoses. 2018 Jul; 61(7):485-497.
    View in: PubMed
    Score: 0.145
  4. Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial. Mycoses. 2018 Jul; 61(7):420-429.
    View in: PubMed
    Score: 0.145
  5. Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial. J Antimicrob Chemother. 2018 03 01; 73(3):757-763.
    View in: PubMed
    Score: 0.144
  6. Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease. J Antimicrob Chemother. 2017 Dec 01; 72(12):3406-3413.
    View in: PubMed
    Score: 0.142
  7. Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis. Lancet Infect Dis. 2016 Jul; 16(7):828-837.
    View in: PubMed
    Score: 0.126
  8. Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis. PLoS One. 2015; 10(6):e0129022.
    View in: PubMed
    Score: 0.120
  9. Successful nonoperative management of gastrointestinal mucormycosis: novel therapy for invasive disease. Surg Infect (Larchmt). 2009 Oct; 10(5):447-51.
    View in: PubMed
    Score: 0.080
  10. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother. 2006 Jan; 50(1):126-33.
    View in: PubMed
    Score: 0.062
  11. International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia. Eur J Clin Microbiol Infect Dis. 2005 Oct; 24(10):654-61.
    View in: PubMed
    Score: 0.061
  12. Needles in a haystack: Extremely rare invasive fungal infections reported in FungiScope?-Global Registry for Emerging Fungal Infections. J Infect. 2020 11; 81(5):802-815.
    View in: PubMed
    Score: 0.043
  13. Histoplasmosis after solid organ transplant. Clin Infect Dis. 2013 Dec; 57(11):1542-9.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.